Transdermal drug delivery: a perspective.
-
1987/02/01
-
Details
-
Personal Author:
-
Description:The use of transdermal drug delivery as a method for systemic drug administration was reviewed. Advantages of transdermal drug delivery included patient compliance, simplicity of administration, immediate reduction of plasma levels of the drug upon removal of the device, reduction in drug related side effects, maintenance of sustained controllable drug levels in the plasma, and elimination of first pass metabolism. The primary limitations of the method were the barrier properties of the skin and potential inflammatory or allergic reactions due to drug bioactivity. The four drugs approved for transdermal delivery in the United States, clonidine, estradiol, nitroglycerin, and scopolamine, and two drugs under experimental review for transdermal methodology, nicotine and timolol, were described. Discussion focused on the physicochemical properties of the drugs and percutaneous absorption modelling in relation to optimal conditions for successful transdermal delivery and problems relating to skin sensitivity, cutaneous metabolism, and tolerance. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0168-3659
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Pages in Document:237-251
-
Volume:4
-
Issue:4
-
NIOSHTIC Number:nn:00185577
-
Citation:J Control Release 1987 Feb; 4(4):237-251
-
Contact Point Address:Pharmacy University of California 926 Medical Sciences Building San Francisco, Calif 94143
-
Federal Fiscal Year:1987
-
Performing Organization:University of California San Francisco, San Francisco, California
-
Peer Reviewed:True
-
Start Date:19840928
-
Source Full Name:Journal of Controlled Release
-
End Date:19871231
-
Collection(s):
-
Main Document Checksum:urn:sha-512:e4b55863a0bd891572fc66d47a68a262799b26fdc5112e3175ab7827b632932170e965bf85cfa9d0b7b16c17624921e8be344c7bcc4824868e962a2c31fc3e3d
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like